Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.
October 8, 2013
ATLANTAThe American College of Rheumatology recently published new research on the importance of folic acid with rheumatic diseases.
Additional studies on rheumatic diseases were also published in Arthritis & Rheumatism and its sister journal Arthritis Care & Research, and all of the studies are published on Wiley Online Library. The studies focused not only on rheumatic diseases but included rheumatoid arthritis, osteoarthritis, systemic lupus erythematosus, juvenile arthritis and fibromyalgia.
According to a new study in Arthritis & Rheumatism, lower levels of folic acid (erythrocyte-folate) are associated wit high disease activity and non-response following three months of treatment with methotrexate, a gold standard therapy for rheumatoid arthritis. The research suggests folic acid levels may predict how patients will respond to methotreaxte. None of the folate biomarkers including homocysteine, vitamin B6, B12 or folic acid were linked to adverse events.
You May Also Like
Tianeptine sales spur another FDA warning, action by state lawmakersFeb 20, 2024
Formulating the future: The industry may not be ready for AI in product development, and AI might not be ready for the industry, eitherFeb 20, 2024
Beyond the primary outcome: How exploratory analysis can deliver unexpected new insightsFeb 19, 2024
Survey shows dietitians concerned about TikTok misinformationFeb 16, 2024